Sort
64,565 grants matching “drug discovery”
Epigenetic mechanisms of inflammatory memory propagation in human airway epithelia
$560,943Alejandro Antonio Pezzulo · University Of Iowa · R01 · FY2023 · HL
CWRU/UHICC Phase I Trials of Anticancer Agents
$560,898Afshin Dowlati · Case Western Reserve University · U01 · FY2007 · CA
Developmental Funds
$560,871Jennifer A Pietenpol · Vanderbilt University · P30 · FY2013 · CA
Optimizing methotrexate use for the management of chronic pediatric non-infectious uveitis
$560,861Sheila Therese Angeles-Han · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · EY
Discovery and development of potent inhibitors of Jun N-terminal kinase for non-hormonal treatment of endometriosis and associated pain
$560,830Stephen Sunderland Palmer · Baylor College Of Medicine · R01 · FY2021 · HD
Development of novel selective Rac inhibitors for refractory leukemias
$560,804David A Williams · Boston Children'S Hospital · R01 · FY2018 · CA
Tagging of Histopathology Specimens with Light-Activated RFID p-Chips
$560,791Wlodek Mandecki · Pharmaseq, Inc. · R44 · FY2012 · GM
A nanomagnetic platform technology to characterize traumatic brain injury using brain derived extracellular vesicles
$560,747David Aaron Issadore · University Of Pennsylvania · R33 · FY2022 · MH
Synthesis and Optimization of the Aleutianamine Class of Alkaloids
$560,675Mark T Hamann · Medical University Of South Carolina · R01 · FY2022 · GM
Acquisition of a Single Crystal X-ray Diffraction System for Macromolecular and Small Molecule Crytsallography
$560,675Karen N. Allen · Boston University (Charles River Campus) · S10 · FY2021 · OD
EEG Signature Analysis for Drug Repurposing for Rare Diseases
$560,641Daniela Brunner · Psychogenics, Inc. · R44 · FY2024 · MH
RAPs-mediated post-transcriptional control in Apicomplexan parasites
$560,570Karine Gaelle Le Roch · University Of California Riverside · R01 · FY2022 · AI
RAPs-mediated post-transcriptional control in Apicomplexan parasites
$560,570Karine Gaelle Le Roch · University Of California Riverside · R01 · FY2019 · AI
RAPs-mediated post-transcriptional control in Apicomplexan parasites
$560,570Karine Gaelle Le Roch · University Of California Riverside · R01 · FY2020 · AI
RAPs-mediated post-transcriptional control in Apicomplexan parasites
$560,570Karine Gaelle Le Roch · University Of California Riverside · R01 · FY2021 · AI
Lipid biosignatures of drug addiction
$560,558Daniele Piomelli · University Of California-Irvine · RC2 · FY2009 · DA
Role of Forkhead proteins in insulin action
$560,520Domenico Accili · Columbia University Health Sciences · R01 · FY2023 · DK
Role of Forkhead proteins in insulin action
$560,520Domenico Accili · Columbia University Health Sciences · R01 · FY2020 · DK
Role of Forkhead proteins in insulin action
$560,520Domenico Accili · Columbia University Health Sciences · R01 · FY2022 · DK
Role of Forkhead proteins in insulin action
$560,520Domenico Accili · Columbia University Health Sciences · R01 · FY2021 · DK
Small molecule antagonists targeting EphB receptors for the treatment of nonalcoholic steatohepatitis (NASH)
$560,483Patrice Mimche · University Of Utah · R01 · FY2023 · DK
Mitochondrial therapeutics for healthy brain aging
$560,473Ronald L Davis · University Of Florida · R33 · FY2023 · AG
Discovery of Chemical Probes for RNA-Binding Protein Host Defense Factors
$560,451Harold C Smith · Oyagen, Inc. · R01 · FY2017 · GM
Develop BCL-xL proteolysis targeting chimeras as safer and better senolytics
$560,435Daohong Zhou · University Of Florida · R01 · FY2019 · AG
Novel System for Automation of Zebrafish Lipid Assays
$560,392Anthony A Ferrante · Physical Sciences, Inc · R44 · FY2006 · DK